RIS and PACS vendors saw it coming a long time ago, a need to make data repositories work with IT the systems that drive workflow. The hybridization of RIS and PACS, preceded by interfaces that allowed the transfer of data between and among systems by different vendors, blazed a trail toward interoperability. This trail has now fanning out to super highway status to accommodate the spread of companies seeking to provide answers to IT questions that must be answered if the Obama initiative is to improve the efficiency of U.S. healthcare.
RIS and PACS vendors saw it coming a long time ago, a need to make data repositories work with IT the systems that drive workflow. The hybridization of RIS and PACS, preceded by interfaces that allowed the transfer of data between and among systems by different vendors, blazed a trail toward interoperability. This trail has now fanning out to super highway status to accommodate the spread of companies seeking to provide answers to IT questions that must be answered if the Obama initiative is to improve the efficiency of U.S. healthcare.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.